Exposure to rituximab did not affect ofatumumab efficacy in CLLHemOncTodayOfatumumab is active in patients with chronic lymphocytic leukemia refractory to fludarabine regardless of prior treatment with rituximab, according to the results of a phase 2 r…
MedPage TodayClinical Context – Multiple SclerosisMedPage TodayTreatment with the monoclonal antibody daclizumab (Zenapax) resulted in significant decreases in contrast-enhancing lesions on MRI in patients with multiple sclerosis (MS), a small, open-…
Selective Screening Before Immunosuppressive Therapy Improves Response Rates …The MDS BeaconMost patients in the study received treatment with cyclosporine (Sandimmune); six patients received treatment first with anti-thymocyte globulin (ATG), follow…
Biovest Defines Role of BiovaxID(R) Personalized Cancer Vaccine in Journal of …MarketWatch (press release)concludes that BiovaxID offers a non-immunosuppressive alternative or potentially complementary approach to rituximab maintenance or radio-immun…
EBV in RA patient marrow strongly predicts rituximab successProHealthMethods: Blood and bone marrow from 35 RA patients were analysed for CMV, EBV, HSV-1, HSV-2, parvovirus B19 and polyomavirus using real-time PCR before and 3 months after rituximab (R…
Proactive Investors USA & CanadaSpectrum says FDA removes bioscan requirement for Zevalin cancer treatmentProactive Investors USA & CanadaPatients that are now undergoing treatment with Zevalin will get two infusions of cancer drug rituximab followed b…
Support for PennyBelper NewsPenny Wheeler, of Beaurepaire Crescent, who has scleroderma and pulmonary fibrosis, should get rituximab on the health service according to Belper's Conservative MP Pauline Latham. Derbyshire County Primary Care Trust sa…
Forecasted Sales of Biosimilar Monoclonal Antibodies for Oncology Indications …MarketWatch (press release)Biosimilar versions of rituximab (Biogen Idec/Roche/Chugai/Zenyaku Kogyo's Rituxan/MabThera) could be approved as early as 2013 in Europe. T…
Rituximab plus chemotherapy improved survival in mantle cell lymphomaHemOncTodayAdding rituximab to standard chemotherapy results in an improvement in OS among older patients with mantle cell lymphoma, results of an observational study indicated. Altho…
Pfizer To Present Clinical Data From Its Hematology Portfolio At The 53rd …Pharmaceutical Processing13,14 Inotuzumab is currently being evaluated in a Phase 3 study in combination with rituximab in patients with relapsed or refractory CD22-positive a…